Selected research
Industry Research
Fosaprepitant Dimeglumine for Injection Industry Research Report 2026
Market perspective
The global Fosaprepitant Dimeglumine for Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fosaprepitant Dimeglumine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fosaprepitant Dimeglumine for Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fosaprepitant Dimeglumine for Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fosaprepitant Dimeglumine for Injection include SPES PHARMACEUTICALS, Sungen Pharma, Aosaikang Pharmaceutical, Hansoh Pharmaceutical, jiuyuan gene engineering, Luoxin Pharmaceuticals, Merck & Co, Qilu Pharmaceutical and Sailong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fosaprepitant Dimeglumine for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fosaprepitant Dimeglumine for Injection Market by Company
SPES PHARMACEUTICALS
Sungen Pharma
Aosaikang Pharmaceutical
Hansoh Pharmaceutical
jiuyuan gene engineering
Luoxin Pharmaceuticals
Merck & Co
Qilu Pharmaceutical
Sailong Pharmaceutical
CTTQ
Sino Biopharmaceutical
Fosaprepitant Dimeglumine for Injection Segment by Type
Original Drug
Generic Drug
Fosaprepitant Dimeglumine for Injection Segment by Application
Hospital
Clinic
Others
Fosaprepitant Dimeglumine for Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosaprepitant Dimeglumine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosaprepitant Dimeglumine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosaprepitant Dimeglumine for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fosaprepitant Dimeglumine for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fosaprepitant Dimeglumine for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fosaprepitant Dimeglumine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital
- Clinic
- Others
Companies covered
- SPES PHARMACEUTICALS
- Sungen Pharma
- Aosaikang Pharmaceutical
- Hansoh Pharmaceutical
- jiuyuan gene engineering
- Luoxin Pharmaceuticals
- Merck & Co
- Qilu Pharmaceutical
- Sailong Pharmaceutical
- CTTQ
- Sino Biopharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fosaprepitant Dimeglumine for Injection Market Size (2021-2032)
- 2.2.2 Global Fosaprepitant Dimeglumine for Injection Sales (2021-2032)
- 2.2.3 Global Fosaprepitant Dimeglumine for Injection Market Average Price (2021-2032)
- 2.3 Fosaprepitant Dimeglumine for Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Original Drug
- 2.3.3 Generic Drug
- 2.4 Fosaprepitant Dimeglumine for Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fosaprepitant Dimeglumine for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fosaprepitant Dimeglumine for Injection Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Fosaprepitant Dimeglumine for Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Fosaprepitant Dimeglumine for Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Fosaprepitant Dimeglumine for Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fosaprepitant Dimeglumine for Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fosaprepitant Dimeglumine for Injection, Product Type & Application
- 3.8 Global Manufacturers of Fosaprepitant Dimeglumine for Injection, Established Date
- 3.9 Global Fosaprepitant Dimeglumine for Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SPES PHARMACEUTICALS
- 4.1.1 SPES PHARMACEUTICALS Company Information
- 4.1.2 SPES PHARMACEUTICALS Business Overview
- 4.1.3 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.1.5 SPES PHARMACEUTICALS Recent Developments
- 4.2 Sungen Pharma
- 4.2.1 Sungen Pharma Company Information
- 4.2.2 Sungen Pharma Business Overview
- 4.2.3 Sungen Pharma Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sungen Pharma Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.2.5 Sungen Pharma Recent Developments
- 4.3 Aosaikang Pharmaceutical
- 4.3.1 Aosaikang Pharmaceutical Company Information
- 4.3.2 Aosaikang Pharmaceutical Business Overview
- 4.3.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.3.5 Aosaikang Pharmaceutical Recent Developments
- 4.4 Hansoh Pharmaceutical
- 4.4.1 Hansoh Pharmaceutical Company Information
- 4.4.2 Hansoh Pharmaceutical Business Overview
- 4.4.3 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.4.5 Hansoh Pharmaceutical Recent Developments
- 4.5 jiuyuan gene engineering
- 4.5.1 jiuyuan gene engineering Company Information
- 4.5.2 jiuyuan gene engineering Business Overview
- 4.5.3 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.5.5 jiuyuan gene engineering Recent Developments
- 4.6 Luoxin Pharmaceuticals
- 4.6.1 Luoxin Pharmaceuticals Company Information
- 4.6.2 Luoxin Pharmaceuticals Business Overview
- 4.6.3 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.6.5 Luoxin Pharmaceuticals Recent Developments
- 4.7 Merck & Co
- 4.7.1 Merck & Co Company Information
- 4.7.2 Merck & Co Business Overview
- 4.7.3 Merck & Co Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck & Co Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.7.5 Merck & Co Recent Developments
- 4.8 Qilu Pharmaceutical
- 4.8.1 Qilu Pharmaceutical Company Information
- 4.8.2 Qilu Pharmaceutical Business Overview
- 4.8.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.8.5 Qilu Pharmaceutical Recent Developments
- 4.9 Sailong Pharmaceutical
- 4.9.1 Sailong Pharmaceutical Company Information
- 4.9.2 Sailong Pharmaceutical Business Overview
- 4.9.3 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.9.5 Sailong Pharmaceutical Recent Developments
- 4.10 CTTQ
- 4.10.1 CTTQ Company Information
- 4.10.2 CTTQ Business Overview
- 4.10.3 CTTQ Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CTTQ Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.10.5 CTTQ Recent Developments
- 4.11 Sino Biopharmaceutical
- 4.11.1 Sino Biopharmaceutical Company Information
- 4.11.2 Sino Biopharmaceutical Business Overview
- 4.11.3 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolio
- 4.11.5 Sino Biopharmaceutical Recent Developments
5 Global Fosaprepitant Dimeglumine for Injection Market Scenario by Region
- 5.1 Global Fosaprepitant Dimeglumine for Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fosaprepitant Dimeglumine for Injection Sales by Region: 2021-2032
- 5.2.1 Global Fosaprepitant Dimeglumine for Injection Sales by Region: 2021-2026
- 5.2.2 Global Fosaprepitant Dimeglumine for Injection Sales by Region: 2027-2032
- 5.3 Global Fosaprepitant Dimeglumine for Injection Revenue by Region: 2021-2032
- 5.3.1 Global Fosaprepitant Dimeglumine for Injection Revenue by Region: 2021-2026
- 5.3.2 Global Fosaprepitant Dimeglumine for Injection Revenue by Region: 2027-2032
- 5.4 North America Fosaprepitant Dimeglumine for Injection Market Facts & Figures by Country
- 5.4.1 North America Fosaprepitant Dimeglumine for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fosaprepitant Dimeglumine for Injection Sales by Country (2021-2032)
- 5.4.3 North America Fosaprepitant Dimeglumine for Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fosaprepitant Dimeglumine for Injection Market Facts & Figures by Country
- 5.5.1 Europe Fosaprepitant Dimeglumine for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2021-2032)
- 5.5.3 Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fosaprepitant Dimeglumine for Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fosaprepitant Dimeglumine for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fosaprepitant Dimeglumine for Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fosaprepitant Dimeglumine for Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fosaprepitant Dimeglumine for Injection Market Facts & Figures by Country
- 5.7.1 South America Fosaprepitant Dimeglumine for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fosaprepitant Dimeglumine for Injection Sales by Country (2021-2032)
- 5.7.3 South America Fosaprepitant Dimeglumine for Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fosaprepitant Dimeglumine for Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fosaprepitant Dimeglumine for Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fosaprepitant Dimeglumine for Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fosaprepitant Dimeglumine for Injection Sales by Type (2021-2032)
- 6.1.1 Global Fosaprepitant Dimeglumine for Injection Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Fosaprepitant Dimeglumine for Injection Revenue by Type (2021-2032)
- 6.2.1 Global Fosaprepitant Dimeglumine for Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Fosaprepitant Dimeglumine for Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fosaprepitant Dimeglumine for Injection Sales by Application (2021-2032)
- 7.1.1 Global Fosaprepitant Dimeglumine for Injection Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Fosaprepitant Dimeglumine for Injection Revenue by Application (2021-2032)
- 7.2.1 Global Fosaprepitant Dimeglumine for Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Fosaprepitant Dimeglumine for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fosaprepitant Dimeglumine for Injection Value Chain Analysis
- 8.1.1 Fosaprepitant Dimeglumine for Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fosaprepitant Dimeglumine for Injection Production Mode & Process
- 8.2 Fosaprepitant Dimeglumine for Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fosaprepitant Dimeglumine for Injection Distributors
- 8.2.3 Fosaprepitant Dimeglumine for Injection Customers
9 Global Fosaprepitant Dimeglumine for Injection Analyzing Market Dynamics
- 9.1 Fosaprepitant Dimeglumine for Injection Industry Trends
- 9.2 Fosaprepitant Dimeglumine for Injection Industry Drivers
- 9.3 Fosaprepitant Dimeglumine for Injection Industry Opportunities and Challenges
- 9.4 Fosaprepitant Dimeglumine for Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst